I think there's a good opportunity to buy this sub- 40c prior to AGM, where I expect upbeat guidance and am hopeful of a re-rating to the stock. Potential catalysts (from a recent 'independent' presso):
-Look to confirm EBTIDA guidance of ~$25m
-Given reduced debt and margin this will see FY13 NPAT ~ FY12 despite II hit
-Underlying growth is higher than was the case in FY12 (rev growth was just 3.7% but FY11 had revenue that was discontinued in FY12)
-Improved investor communication / transparency / understanding of change in model
-Ultimate catalyst: Dividends resume with Net Debt to EBITDA ~2x
- Forums
- ASX - By Stock
- Ann: Intravitreal Injections
I think there's a good opportunity to buy this sub- 40c prior to...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VEI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online